{"id":"NCT01896193","sponsor":"Gilead Sciences","briefTitle":"Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection","officialTitle":"A Phase 3b, Multicenter, Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naïve Adults With Genotype 1 and 3 Chronic HCV Infection.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2014-04","completion":"2014-06","firstPosted":"2013-07-11","resultsPosted":"2015-04-17","lastUpdate":"2015-05-29"},"enrollment":127,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"SOF","otherNames":["Sovaldi®","PSI-7977","GS-7977"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"SOF+RBV 16 Weeks","type":"EXPERIMENTAL"},{"label":"SOF+RBV 24 Weeks","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the antiviral efficacy, safety, and tolerability of sofosbuvir plus ribavirin administered for 16 weeks and 24 weeks in participants with chronic genotype 1 (GT1) or genotype 3 (GT3) hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) at 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"SOF+RBV 16 Weeks, GT1","deltaMin":50,"sd":null},{"arm":"SOF+RBV 24 Weeks, GT1","deltaMin":76.5,"sd":null},{"arm":"SOF+RBV 16 Weeks, GT3","deltaMin":86.7,"sd":null},{"arm":"SOF+RBV 24 Weeks, GT3","deltaMin":90.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":16,"countries":["Russia"]},"refs":{"pmids":["27376706"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":62},"commonTop":["Headache","Asthenia","Respiratory tract infection viral","Fatigue","Insomnia"]}}